Xsolla Founder Shurick Agapitov Releases Once Upon Tomorrow Fortnite Island: A Groundbreaking Immersive Experience That Brings the Novel's Universe to Life
12.12.2024 15:00:00 CET | Business Wire | Press release
High-Octane Parkour Challenges Meet Story-Driven Gameplay in a New Fortnite Creative Map Inspired by Once Upon Tomorrow
Shurick Agapitov, founder of Xsolla and visionary in the gaming industry, proudly announces the Once Upon Tomorrow Fortnite Island release. This immersive Fortnite Creative map transports players into the rich narrative world of his novel. The innovative experience, developed in Unreal Editor for Fortnite (UEFN), masterfully combines high-speed parkour challenges with deep thematic elements from Once Upon Tomorrow, inviting players to test their skills while journeying through a visually captivating landscape that embodies the resilience and adventure of the book’s characters.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212923969/en/
(Graphic: Xsolla)
“Once Upon Tomorrow in Fortnite Creative is our way of expanding the reach and depth of the novel, offering players an interactive journey that challenges both their skills and their understanding of the story’s themes,” said Shurick Agapitov, Founder of Xsolla. “We designed this map to captivate players who crave a good challenge and to immerse them in a world that’s visually rich and deeply inspired by the book. It’s an adventure that leverages UEFN’s technical strengths to elevate storytelling in Fortnite in a way that truly transforms the game experience.”
Designed to push the boundaries of Fortnite Creative, Once Upon Tomorrow offers players a dynamic, narrative-driven parkour adventure set within a meticulously crafted environment inspired by Agapitov’s book and vision. Each course presents a series of agility-based challenges that require players to sprint, leap, and climb with precision and speed, all while immersed in a world filled with visual cues that echo the themes of endurance and discovery central to the book. Agapitov has created an experience beyond traditional parkour maps by weaving gameplay with storytelling, delivering both exhilarating gameplay and a meaningful connection to the novel’s world.
Once Upon Tomorrow is a project within Fortnite Creative, seamlessly blending high-stakes parkour with narrative depth. The map is a testament to what can be achieved using UEFN, offering an engaging and multi-layered experience that appeals to Fortnite’s extensive player base and fans of novel and narrative-rich gaming experiences. Every aspect of the map—from its intense gameplay mechanics to its immersive, atmospheric design—has been crafted to set a new standard in Fortnite Creative.
For more information about Once Upon Tomorrow and its immersive Fortnite Creative experience, please visit xsolla.blog/outf
About Shurick Agapitov
Shurick Agapitov is the visionary founder of Xsolla, a globally recognized leader in video game commerce. Known for his contributions to gaming, Web3, and the metaverse, Agapitov has driven Xsolla to become a vital resource for game developers and publishers worldwide. His dedication to enhancing digital and interactive experiences is reflected in the launch of Once Upon Tomorrow, extending his vision beyond the page to the dynamic world of Fortnite Creative.
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world, Xsolla supports leading gaming partners such as Valve, Twitch, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, among others.
For additional information and to learn more, please visit xsolla.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241212923969/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom